Canagliflozin Prevents Lipid Accumulation, Mitochondrial Dysfunction, and Gut Microbiota Dysbiosis in Mice With Diabetic Cardiovascular Disease

Xueliang Wang(Sun Yat-sen University), Guangli Yu(Qingdao National Laboratory for Marine Science and Technology)
Frontiers in Pharmacology
February 23, 2022
Cited by 24


Related Papers